Evidence map›Paper›PMID 26291319›Full record

ReviewPLoS pathogens2015

Hepcidin and Host Defense against Infectious Diseases.

Kathryn Michels, Elizabeta Nemeth, Tomas Ganz, Borna Mehrad

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07523646 (Anemia Therapy in Patients With Infective Endocarditis), which is not on this map. Cited by 100 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 1 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07523646 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Anemia Therapy in Patients With Infective Endocarditis (POET-IRON)

TypeinterventionalSponsorRigshospitalet, DenmarkRan2026 to 2028Enrolled74ConditionsInfective Endocarditis (IE), Severe AnemiaArmsAdjunctive anemia therapy
3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 1 synthesis or guideline pooled it, 210 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. A hepcidin homolog fromVirulence · 2026
    Article
  4. mBio · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. SLC11A2 affects nutritional immunity in the gut epithelium.bioRxiv : the preprint server for biology · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Evasive mechanisms of human VSG and PfEMP1 antigens with link to Vaccine scenario: a review.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Review
  14. Review
  15. Clinical characteristics ofFrontiers in medicine · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kathryn MichelsDepartments of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, United States of America.
Elizabeta NemethDepartment of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States of America.
Tomas GanzDepartment of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States of America; Department of Pathology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, United States of America.
Borna MehradDepartments of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, United States of America; The Carter Center for Immunology, University of Virginia, Charlottesville, Virginia, United States of America; Department of Internal Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
University of California, Los Angeles · USCarter Center · USUniversity of Virginia · US

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
Hepcidin therapy for iron overload and hematologic disordersR01DK090554 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI RIVELLA, STEFANO · 2010 to 2021
$5.2M
Ferroportin Structure and functionR01DK107309 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JORMAKKA, MIKA, MACKENZIE, BRYAN · 2015 to 2019
$3.0M
Fibrocytes in human pulmonary fibrosisR01HL098329 · NHLBI · UNIVERSITY OF VIRGINIA · PI MEHRAD, BORNA, ROSE, C EDWARD · 2011 to 2015
$2.7M
Fibrocytes in the Pathogenesis of Sickle Cell Lung DiseaseR01HL098526 · NHLBI · UNIVERSITY OF VIRGINIA · PI ROSE, C EDWARD · 2010 to 2013
$2.0M
Neutrophils and adaptive immunity against invasive aspergillosisR21AI117397 · NIAID · UNIVERSITY OF VIRGINIA · PI MEHRAD, BORNA · 2015 to 2016
$435k
NHLBI NIH HHS HL098329NHLBI NIH HHS HL098526NHLBI NIH HHS R01 HL098329NHLBI NIH HHS R01 HL098526NIAID NIH HHS AI117397NIAID NIH HHS R21 AI117397NIAID NIH HHS T32 AI007046NIDDK NIH HHS DK090554NIDDK NIH HHS R01 DK090554NIDDK NIH HHS R01 DK107309
6 · The paper itself

Abstract

Hepcidin is the master regulator of iron homeostasis in vertebrates. The synthesis of hepcidin is induced by systemic iron levels and by inflammatory stimuli. While the role of hepcidin in iron regulation is well established, its contribution to host defense is emerging as complex and multifaceted. In this review, we summarize the literature on the role of hepcidin as a mediator of antimicrobial immunity. Hepcidin induction during infection causes depletion of extracellular iron, which is thought to be a general defense mechanism against many infections by withholding iron from invading pathogens. Conversely, by promoting iron sequestration in macrophages, hepcidin may be detrimental to cellular defense against certain intracellular infections, although critical in vivo studies are needed to confirm this concept. It is not yet clear whether hepcidin exerts any iron-independent effects on host defenses.

Indexed as

AnimalsCommunicable DiseasesHepcidinsHumansHepcidins

Identifiers

PMID26291319
PMCPMC4546197
OpenAlexW1141274631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.